Skip to main content
Glama

Gets Nz

by io.github.pipeworx-io

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
-  "company"
-]New value: +[
+  "company",
+  "ticker"
+]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Goes well beyond the readOnly/idempotent annotations by detailing fan-out sources, `sources_used`/`sources_failed` semantics, the patents soft-fail, expected-empty FDA product sections, and private-company resolved:false behavior. These are exactly the behavioral quirks an agent needs to interpret results correctly.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Front-loaded with purpose and usage examples, and every sentence carries substantive information. The large return-section list is packed into one dense paragraph; bullets would improve scannability, but nothing is redundant for the tool's complexity.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description enumerates every return section, source coverage, failure semantics, and input resolution behavior. An agent can invoke this tool and interpret its response without ambiguity.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so the parameters are already fully documented. The description adds useful examples and reiterates interchangeability, but most of the added context concerns output behavior rather than new parameter meaning, so baseline 3 is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

States exactly what the tool does — returns a full multi-source profile of a US public company in one call — and supports it with concrete user phrasings. It explicitly distinguishes itself from chaining single-pack SEC/XBRL/news lookups, so an agent can route holistic inquiries here confidently.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives an explicit ALWAYS PREFER directive for holistic-company-view requests over chain-of-single-topic lookups, and explains the three accepted input forms plus the private-company edge case. This is actionable routing guidance, not just a vague capability statement.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Gets Nz toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Multiple tools overlap significantly: ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded serve nearly identical purposes, and deep_research further duplicates. Polymarket tools (bet_research, polymarket_arbitrage, polymarket_edges, etc.) also have overlapping scopes, making it hard for an agent to select the correct one without deep inspection.

Naming Consistency3/5

Tool names use a mix of patterns: some are descriptive phrases (ai_visibility_check, generate_llms_txt), others are domain-prefixed (nz_tender_*, polymarket_*) but lack a uniform verb_noun structure. The ask_pipeworx series diverges from the rest, and verb choices are inconsistent (compare_entities vs scan_competitor_ai_presence).

Tool Count2/5

With 34 tools, the surface is large and feels bloated. The server covers multiple distinct domains (NZ tenders, Polymarket, memory, subscriptions) that could be separate servers. Many tools are variants of the same core functionality (e.g., four ask_pipeworx variants), inflating the count without clear necessity.

Completeness3/5

For a general-purpose data query server, the tool set covers a broad range of sources (SEC, FDA, FRED, etc.) and includes CRUD for memory and subscriptions. However, obvious gaps exist: no dedicated web search tool (ask_pipeworx is for structured data), and NZ coverage is limited to tenders only. Missing update/delete for some resources (e.g., no way to modify a subscription beyond unsubscribe).

Resources